Stocks and InvestingStocks and Investing
Mon, February 27, 2023
Sun, February 26, 2023
Sat, February 25, 2023
Fri, February 24, 2023

Joseph Stringer Reiterated (VIR) at Strong Buy and Held Target at $32 on, Feb 24th, 2023


Published on 2024-10-28 01:54:48 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $32 on, Feb 24th, 2023.

Joseph has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $30 on, Friday, January 27th, 2023


These are the ratings of the 3 analyists that currently disagree with Joseph


  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $53 on, Thursday, February 23rd, 2023
  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $43 on, Friday, January 27th, 2023
  • Andrew Galler of "Morgan Stanley" Maintained at Sell with Increased Target to $18 on, Friday, November 4th, 2022